Ability Pharma
Founded 2009 · 20 employees on LinkedIn · 2 known investors
AbilityPharma is a biopharmaceutical company developing first-in-class drug candidates for cancer, using autophagy as a therapeutic strategy to selectively induce cell death in cancer cells. Its lead candidate ABTL0812 (ibrilatazar) has completed a phase 2b trial in metastatic pancreatic cancer across the USA, Spain, France, and Israel.
Investors · 2
Frequently asked questions
- What does Ability Pharma do?
- AbilityPharma is a biopharmaceutical company developing first-in-class drug candidates for cancer, using autophagy as a therapeutic strategy to selectively induce cell death in cancer cells. Its lead candidate ABTL0812 (ibrilatazar) has completed a phase 2b trial in metastatic pancreatic cancer across the USA, Spain, France, and Israel.
- Who are Ability Pharma's investors?
- Ability Pharma's investors include Capital Cell, CTI Life Sciences Fund L.P..